PATENT CLAIM ANALYSIS

Application Number: 15915842
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "455000"]

Abstract:
The invention provides a compound of formula (I) wherein: A, B, C, D, W, X, Y and Z are each independently selected from H and OH; or a salt thereof; for use in the treatment and/or prophylaxis of a condition, disease or disorder in a subject, wherein the compound or salt is orally administered to a subject in a daily amount of from 2.8 to 6.6 mmol per day, over a period of at least 21 days. Also are provided are the compound of formula (I) for use in increasing mitophagy and/or autophagy, maintaining and/or improving muscle function and administration as a dietary, nutritional and/or health supplement.

Claim (Index 12):
The method of  claim 1 , wherein the disease, disorder or condition is selected from the group consisting of obesity, reduced metabolic rate, metabolic syndrome, metabolic stress, diabetes mellitus, cardiovascular disease, hyperlipidemia, memory decline, neurodegenerative diseases, cognitive disorder, mood disorder, stress, and anxiety disorder, fatty liver disease, musculoskeletal diseases and disorders, muscle-wasting, muscle degenerative disease, myopathies, age-related decline in muscle function, frailty, pre-frailty, neuromuscular diseases, Duchenne muscular dystrophy, sarcopenia, muscle atrophy or cachexia, ICUAW, muscle loss, memory loss, vision loss, hearing loss, a joint disorder, a muscle function disorder, age-related decline in muscle function, age-related sarcopenia, age-related muscle-wasting, physical fatigue, muscle fatigue, inclusion body myositis, sporadic inclusion body myositis, alcoholic liver disease, non-alcoholic fatty liver disease, drug-induced liver injury, acute or chronic kidney failure, acute or chronic toxicity induced by chemotherapy (for example Nephrotoxicity, Neurotoxicity, Ototoxicity), drug-induced cravings, anaemia disorders, al-antitrypsin deficiency, ischemia/reperfusion injury, inflammation, inflammatory bowel disease, Crohn's disease, osteoarthritis, Alzheimer's disease, Parkinson's disease, ulceration, amyotrophic lateral sclerosis, cancer, cognitive disorder, stress, and mood disorder.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.64935
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15218790', '15757293', '13336841', '15532280', '11908952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8174057772885643
- 35 USC 102 Novelty (BERT): 0.5136077949706944
- Combined Prediction Score: 0.7870259790567773
- Mean Citation Score: 265.293968
- Max Citation Score: 272.13947
- Similarity Product: 174.31397867439986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test